{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:04:57Z","timestamp":1773083097342,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1136\/ard.2006.062919","type":"journal-article","created":{"date-parts":[[2007,5,2]],"date-time":"2007-05-02T15:40:07Z","timestamp":1178120407000},"page":"1450-1455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis"],"prefix":"10.1016","volume":"66","author":[{"given":"Marja-Kaisa","family":"Koivula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku","family":"Heli\u00f6vaara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarmo","family":"Ramberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Knekt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harri","family":"Rissanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Palosuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha","family":"Risteli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2006.062919_bib1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/07853890410026025","article-title":"Risk factors for rheumatoid arthritis","volume":"36","author":"Aho","year":"2004","journal-title":"Ann Med"},{"key":"10.1136\/ard.2006.062919_bib2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/rheumatology\/kei240","article-title":"The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis","volume":"45","author":"Manfredsdottir","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2006.062919_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.062919_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cccn.2004.07.016","article-title":"Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker","volume":"350","author":"Nijenhuis","year":"2004","journal-title":"Clin Chem Acta"},{"key":"10.1136\/ard.2006.062919_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2741\/1506","article-title":"Citrullinated proteins in rheumatoid arthritis","volume":"10","author":"Yamada","year":"2005","journal-title":"Front Biosci"},{"key":"10.1136\/ard.2006.062919_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.molmed.2003.08.007","article-title":"Association of PADI4 and rheumatoid arthritis: a successful multidisciplinary approach","volume":"9","author":"Worthington","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1136\/ard.2006.062919_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.molmed.2003.09.010","article-title":"Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene","volume":"9","author":"Yamada","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1136\/ard.2006.062919_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2003.012211","article-title":"Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages","volume":"63","author":"Vossenaar","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.062919_bib9","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/rheumatology\/kei023","article-title":"Citrullination of fibronectin in rheumatoid arthritis synovial tissue","volume":"44","author":"Chang","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2006.062919_bib10","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1186\/ar1845","article-title":"Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis","volume":"7","author":"Kinloch","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2006.062919_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-4684-3282-4_17","article-title":"The enzymic derivation of citrulline residues from arginine residues in situ during the biosynthesis of hair proteins that are cross-linked by isopeptide bonds","volume":"86A","author":"Rogers","year":"1977","journal-title":"Adv Exp Med Biol"},{"key":"10.1136\/ard.2006.062919_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrc.2005.12.160","article-title":"Identification of citrullinated eukaryotic translation initiation factor 4G1 as novel autoantigen in rheumatoid arthritis","volume":"341","author":"Okazaki","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/ard.2006.062919_bib13","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/eji.200526000","article-title":"Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis","volume":"35","author":"Burkhardt","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.2006.062919_bib14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bbrc.2005.05.137","article-title":"Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis","volume":"333","author":"Suzuki","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/ard.2006.062919_bib15","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1136\/ard.2004.031211","article-title":"Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?","volume":"64","author":"Koivula","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.062919_bib16","first-page":"2743","article-title":"Antifilaggrin antibodies within \u201cnormal\u201d range predict rheumatoid arthritis in a linear fashion","volume":"27","author":"Aho","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.062919_bib17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/art.1780280503","article-title":"When does rheumatoid disease start?","volume":"28","author":"Aho","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.062919_bib18","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.1780350810","article-title":"Immunopathology of rheumatoid arthritis: antikeratin antibodies precede the clinical disease","volume":"35","author":"Kurki","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.062919_bib19","first-page":"1278","article-title":"Antikeratin antibody and antiperinuclear factor as underlying markers for rheumatoid disease process","volume":"20","author":"Aho","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.062919_bib20","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.062919_bib21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.062919_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.062919_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and predictive values of anti-CCP (cyclic citrullinated protein) antibodies in rheumatoid arthritis: a systematic literature review","volume":"85","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.062919_bib24","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1515\/CCLM.2005.239","article-title":"Sensitive immunoassays for the autoantibodies reacting against citrullinated carboxy-terminal telopeptides of type I and type II collagens in patients with rheumatoid arthritis","volume":"43","author":"Koivula","year":"2005","journal-title":"Clin Chem Lab Med"},{"issue":"suppl 673","key":"10.1136\/ard.2006.062919_bib25","first-page":"1","article-title":"The Social Insurance Institution's coronary heart disease study. Baseline data and 5-years mortality experience","volume":"214","author":"Reunanen","year":"1983","journal-title":"Acta Med Scand"},{"key":"10.1136\/ard.2006.062919_bib26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.56.6.351","article-title":"Serum immunoglobulins and the risk of rheumatoid arthritis","volume":"56","author":"Aho","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.062919_bib27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/ard.57.5.281","article-title":"Serum androgen-anabolic hormones and the risk of rheumatoid arthritis","volume":"57","author":"Heikkil\u00e4","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.062919_bib28","first-page":"149","article-title":"Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis","volume":"13","author":"Myllykangas-Luosuj\u00e4rvi","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2006.062919_bib29","first-page":"1674","article-title":"The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement","volume":"20","author":"Hakala","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.062919_bib30","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/ard.55.9.608","article-title":"Incidence of rheumatoid arthritis in Finland during 1980\u20131990","volume":"55","author":"Kaipiainen-Sepp\u00e4nen","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.062919_bib31","first-page":"248","volume":"32","author":"Breslow","year":"1980"},{"key":"10.1136\/ard.2006.062919_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/rheumatology\/kei111","article-title":"Use and significance of anti-CCP autoantibodies in rheumatoid arthritis","volume":"45","author":"Zendman","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2006.062919_bib33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/1744666X.2.3.365","article-title":"Pathogenic role of antibodies to citrullinated proteins in rheumatoid arthritis","volume":"2","author":"Kinloch","year":"2006","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1136\/ard.2006.062919_bib34","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","article-title":"The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the \u03b1- and \u03b2-chains of fibrin","volume":"166","author":"Masson-Bessiere","year":"2001","journal-title":"J Immunol"},{"key":"10.1136\/ard.2006.062919_bib35","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","article-title":"Rheumatoid arthritis specific anti-SA antibodies target citrullinated vimentin","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2006.062919_bib36","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.autrev.2005.04.018","article-title":"Anti-citrullinated protein\/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor","volume":"4","author":"Van der Cruyssen","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard.2006.062919_bib37","first-page":"1377","article-title":"Antinuclear antibodies heralding the onset of systemic lupus erythematosus","volume":"19","author":"Aho","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.062919_bib38","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0140-6736(94)92521-6","article-title":"Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease","volume":"343","author":"Tuomilehto","year":"1994","journal-title":"Lancet"},{"key":"10.1136\/ard.2006.062919_bib39","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1126\/science.300.5627.1862","article-title":"Clinical trials. Diabetes' brave new world","volume":"300","author":"Couzin","year":"2003","journal-title":"Science"},{"key":"10.1136\/ard.2006.062919_bib40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1586\/1744666X.3.2.187","article-title":"Citrullinated collagens in the pathogenesis of rheumatoid arthritis","volume":"3","author":"Risteli","year":"2007","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1136\/ard.2006.062919_bib41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ab.2006.02.007","article-title":"Specific modifications of peptide-bound citrulline residues","volume":"352","author":"Holm","year":"2006","journal-title":"Anal Biochem"},{"key":"10.1136\/ard.2006.062919_bib42","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/rheumatology\/kel113","article-title":"Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis","volume":"45","author":"Koivula","year":"2006","journal-title":"Rheumatology (Oxford)"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724346151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724346151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2006.062919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:30:26Z","timestamp":1736123426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724346151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0003496724346151"],"URL":"https:\/\/doi.org\/10.1136\/ard.2006.062919","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2006.062919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 2007 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}